West Penn Allegheny Oncology Network

What West Penn Allegheny Oncology Network does

West Penn Allegheny Oncology Network is a regional oncology care delivery entity operating within Allegheny Health Network (AHN), which is itself part of the Highmark Health integrated payor-provider system. The network delivers comprehensive, multi-disciplinary cancer care across western Pennsylvania through hospital-based cancer institutes and community outpatient cancer centers, including sites at Allegheny General, West Penn, Beaver, Butler, Forbes, Grove City, Hempfield, Kittanning, and New Castle. Its service portfolio spans medical oncology, radiation oncology, surgical oncology, hematology, cellular therapy, immunotherapy, precision medicine and genomics, and an active clinical trials program that includes the Regional Immuno-Oncology Trial (RIOT).

The network's core platform combines clinical care delivery with care-coordination infrastructure, notably the AHN Cancer Navigation Team that guides patients across the multi-site system. Specialized programs include the Breast Cancer Center of Excellence, Metastatic Breast Cancer Clinic, Young Women's Breast Cancer Initiative, and After Hours Oncology Clinic, supplemented by telehealth and video visit services. Through the Highmark Cancer Collaborative, the network maintains a strategic academic partnership with Johns Hopkins Kimmel Cancer Center, enabling access to clinical trials and specialized expertise that would otherwise require patient travel outside the region.

The business model follows conventional U.S. hospital and ambulatory oncology economics: services are billed through insurance reimbursement, with financial assistance for uninsured patients and standard price transparency disclosures through hospital charges listings. Pricing details are not publicly disclosed in the source material. End customers are individual cancer patients across western Pennsylvania seeking diagnosis, treatment, and survivorship care; payer concentration and parent-system capital allocation are the primary structural dependencies rather than any single patient or employer counterparty. No revenue, funding, headcount-trend, or ownership details specific to West Penn Allegheny Oncology Network as a discrete legal entity were disclosed in the available data, though contextual signals tie it firmly into the AHN/Highmark Health ecosystem.

Name

West Penn Allegheny Oncology Network

Website

https://wpaon.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

West Penn Allegheny Oncology Network is a regional cancer care delivery entity within Allegheny Health Network, providing multi-disciplinary oncology services across nine western Pennsylvania hospital and outpatient sites for patients seeking comprehensive cancer diagnosis, treatment, and survivorship care.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Other Outpatient Care Centers (62149), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Oncology services
• Cancer treatment
• Radiation oncology
• Medical oncology
• Clinical trials

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Distribution channels3 records

Marketing channels4 records

Core offering

West Penn Allegheny Oncology Network delivers comprehensive cancer care to patients through an integrated western Pennsylvania network of hospital-based cancer institutes and outpatient centers. Services span medical oncology, radiation oncology, surgical oncology, cellular therapy, immunotherapy, precision cancer medicine and genomics, survivorship programs, and access to clinical trials including the Regional Immuno-Oncology Trial (RIOT) program, with patient navigation across the care journey.

Product overview

West Penn Allegheny Oncology Network operates as part of Allegheny Health Network (AHN), offering comprehensive cancer care services through a network of cancer institutes and specialized programs. The portfolio includes the AHN Cancer Institute at West Penn Hospital with medical oncology, radiation oncology, and hematology divisions; specialized centers of excellence for breast cancer and other cancer types; patient navigation services; and partnership programs with organizations like the Highmark Cancer Collaborative and Johns Hopkins Kimmel Cancer Center for advanced treatment access.

Differentiator

Problem solved

Functional benefit

Products and services

• AHN Cancer Institute at West Penn Hospital A comprehensive cancer treatment center providing medical oncology, radiation oncology, and hematology services at the West Penn Hospital campus in Pittsburgh for cancer patients in western Pennsylvania.
• Medical Oncology Division Clinical service providing chemotherapy, immunotherapy, targeted therapy, and other medical treatments for various cancer types to patients referred for systemic cancer therapy.
• Radiation Oncology Division Clinical service offering advanced radiation therapy treatments including external beam radiation, brachytherapy, and specialized techniques such as Gamma Knife and GammaTile for cancer patients requiring radiation therapy.
• Breast Cancer Center of Excellence Specialized program providing dedicated breast cancer diagnosis, treatment, and survivorship care with multidisciplinary care teams for breast cancer patients.
• Metastatic Breast Cancer Clinic Specialized clinic dedicated to patients with metastatic breast cancer, focused on advanced treatment options, clinical trials access, and ongoing disease management.
• Clinical Trials Program Active oncology clinical trials program providing patients access to investigational cancer treatments, including the Regional Immuno-Oncology Trial (RIOT) Program for immunotherapy clinical trials.
• Cancer Navigation Team Patient support service providing guidance to cancer patients throughout their treatment journey, including help navigating appointments, resources, and care coordination across the AHN network.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Johns Hopkins Kimmel Cancer CentercoreStrategic or Co-development PartnerCollaboration through the Highmark Cancer Collaborative, bringing together the brightest minds in cancer care. The partnership enables access to Johns Hopkins expertise and advances cancer treatment research and clinical excellence within the AHN network.
• Highmark HealthcoreStrategic or Co-development PartnerHighmark Cancer Collaborative partnership bringing together Highmark's healthcare delivery network with academic and clinical partners to advance cancer care quality, research, and patient outcomes.

Scale indicators1 record

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Cleveland Clinic Taussig Cancer Center: NCI-designated comprehensive cancer center in Cleveland providing the full spectrum of oncology services plus research and specialized programs. Comparable to WPAON's tertiary node at West Penn Hospital and a competing referral destination for western Pennsylvania patients.
• City of Hope: National NCI-designated cancer center and system with an expanding regional network model delivering advanced oncology, cellular therapy, and clinical trials. Comparable to WPAON's tertiary-plus-community approach and a benchmark for scaling community oncology with academic expertise.
• Penn Medicine Abramson Cancer Center: University of Pennsylvania's NCI-designated cancer center, offering advanced oncology, clinical trials, and precision medicine. Comparable as a tertiary/academic oncology partner and a competing destination for complex cancer cases in the broader Pennsylvania region.

Emerging players

• OneOncology: Network platform partnering with independent community oncology practices to deliver medical oncology, infusion, and clinical trials at scale. Highly comparable to WPAON's community-hospital oncology model and a potential disruptor or partner for AHN's community oncology footprint.
• Heritage Valley Health System Cancer Care: Smaller community hospital-affiliated oncology program in western Pennsylvania offering medical oncology and infusion services. Comparable to WPAON's community-hospital outpatient nodes and a direct micro-competitor for patient referrals in overlapping western PA counties.

Regional players

• Geisinger Cancer Institute: Geisinger's integrated cancer program across central and northeastern Pennsylvania offers comparable multidisciplinary oncology services, including precision medicine and clinical trials. It competes for Pennsylvania patients and shares academic/affiliation partnerships with tertiary centers.
• University Hospitals Seidman Cancer Center: NCI-designated cancer program in Cleveland providing comprehensive oncology services across the UH system. Comparable as an academic-affiliated regional network attracting western Pennsylvania patients and competing for clinical talent in adjacent markets.
• OhioHealth Cancer Care: Integrated community-based oncology program across central Ohio providing medical, radiation, and surgical oncology with clinical trials. Comparable to WPAON as a regional, hospital-affiliated multidisciplinary network competing for patients in a neighboring state.

Direct peers

• Quality Cancer Care Alliance (QCCA): Network of independent oncology practices offering community-based medical oncology, infusion, and clinical trials. Comparable to WPAON in scale and community-anchored delivery model, and a gauge for how regional oncology networks monetized via pharma services and value-based contracts.
• UPMC Hillman Cancer Center: UPMC's NCI-designated comprehensive cancer center in Pittsburgh, offering the same multi-modality oncology services (medical, radiation, surgical, clinical trials) across western Pennsylvania. It is the principal local competitor for patient referrals, clinical trial enrollment, and specialist physician talent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/west-penn-allegheny-oncology-network

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about West Penn Allegheny Oncology Network